402 related articles for article (PubMed ID: 29340540)
1. Toxic epidermal necrolysis: a paradigm of critical illness.
Estrella-Alonso A; Aramburu JA; González-Ruiz MY; Cachafeiro L; Sánchez MS; Lorente JA
Rev Bras Ter Intensiva; 2017; 29(4):499-508. PubMed ID: 29340540
[TBL] [Abstract][Full Text] [Related]
2. Toxic epidermal necrolysis (Lyell syndrome).
Roujeau JC; Chosidow O; Saiag P; Guillaume JC
J Am Acad Dermatol; 1990 Dec; 23(6 Pt 1):1039-58. PubMed ID: 2273103
[TBL] [Abstract][Full Text] [Related]
3. Cyclosporine for Epidermal Necrolysis: Absence of Beneficial Effect in a Retrospective Cohort of 174 Patients-Exposed/Unexposed and Propensity Score-Matched Analyses.
Poizeau F; Gaudin O; Le Cleach L; Duong TA; Hua C; Hotz C; Ingen-Housz-Oro S; Sbidian E; Zehou O; Colin A; de Prost N; Lebrun-Vignes B; Chosidow O; Wolkenstein P; Fardet L
J Invest Dermatol; 2018 Jun; 138(6):1293-1300. PubMed ID: 29369774
[TBL] [Abstract][Full Text] [Related]
4. Toxic epidermal necrolysis: Part II. Prognosis, sequelae, diagnosis, differential diagnosis, prevention, and treatment.
Schwartz RA; McDonough PH; Lee BW
J Am Acad Dermatol; 2013 Aug; 69(2):187.e1-16; quiz 203-4. PubMed ID: 23866879
[TBL] [Abstract][Full Text] [Related]
5. Retrospective review of Stevens-Johnson syndrome/toxic epidermal necrolysis treatment comparing intravenous immunoglobulin with cyclosporine.
Kirchhof MG; Miliszewski MA; Sikora S; Papp A; Dutz JP
J Am Acad Dermatol; 2014 Nov; 71(5):941-7. PubMed ID: 25087214
[TBL] [Abstract][Full Text] [Related]
6. Severe cutaneous adverse reactions to drugs.
Chia FL; Leong KP
Curr Opin Allergy Clin Immunol; 2007 Aug; 7(4):304-9. PubMed ID: 17620821
[TBL] [Abstract][Full Text] [Related]
7. Guidelines for the management of Stevens-Johnson syndrome/toxic epidermal necrolysis: An Indian perspective.
Gupta LK; Martin AM; Agarwal N; D'Souza P; Das S; Kumar R; Pande S; Das NK; Kumaresan M; Kumar P; Garg A; Singh S
Indian J Dermatol Venereol Leprol; 2016; 82(6):603-625. PubMed ID: 27716721
[TBL] [Abstract][Full Text] [Related]
8. Cyclosporine in toxic epidermal necrolysis: a brief review of the emerging therapeutic modality.
Kumar P; Kanti Das N
Dermatol Online J; 2016 Oct; 22(10):. PubMed ID: 28329582
[TBL] [Abstract][Full Text] [Related]
9. Effectiveness, safety and tolerability of cyclosporine versus supportive treatment in Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis: A record-based study.
Mohanty S; Das A; Ghosh A; Sil A; Gharami RC; Bandyopadhyay D; Das NK
Indian J Dermatol Venereol Leprol; 2017; 83(3):312-316. PubMed ID: 28366923
[TBL] [Abstract][Full Text] [Related]
10. Ocular sequelae of epidermal necrolysis: French national audit of practices, literature review and proposed management.
Thorel D; Ingen-Housz-Oro S; Benaïm D; Daien V; Gabison E; Saunier V; Béral L; Touboul D; Brémond-Gignac D; Robert M; Vasseur R; Royer G; Dereure O; Milpied B; Bernier C; Welfringer-Morin A; Bodemer C; Cordel N; Tauber M; Burillon C; Servant M; Couret C; Vabres B; Tétart F; Cassagne M; Kuoch MA; Muraine M; Delcampe A; Gueudry J
Orphanet J Rare Dis; 2023 Mar; 18(1):51. PubMed ID: 36906580
[TBL] [Abstract][Full Text] [Related]
11. Management of toxic epidermal necrolysis in a pediatric burn center.
Adzick NS; Kim SH; Bondoc CC; Quinby WC; Remensnyder JP
Am J Dis Child; 1985 May; 139(5):499-502. PubMed ID: 3920898
[TBL] [Abstract][Full Text] [Related]
12. Toxic epidermal necrolysis (TEN): the Chelsea and Westminster Hospital wound management algorithm.
Abela C; Hartmann CE; De Leo A; de Sica Chapman A; Shah H; Jawad M; Bunker CB; Williams GJ; Leon-Villapalos J
J Plast Reconstr Aesthet Surg; 2014 Aug; 67(8):1026-32. PubMed ID: 24860933
[TBL] [Abstract][Full Text] [Related]
13. Stevens-Johnson syndrome and toxic epidermal necrolysis: a review of the literature.
Letko E; Papaliodis DN; Papaliodis GN; Daoud YJ; Ahmed AR; Foster CS
Ann Allergy Asthma Immunol; 2005 Apr; 94(4):419-36; quiz 436-8, 456. PubMed ID: 15875523
[TBL] [Abstract][Full Text] [Related]
14. Managing the ADR of Stevens-Johnson syndrome/toxic epidermal necrolysis.
Lian BS; Lee HY
Expert Opin Drug Saf; 2022 Aug; 21(8):1039-1046. PubMed ID: 35878014
[TBL] [Abstract][Full Text] [Related]
15. Tear exchangeable limbal rigid contact lens for ocular sequelae resulting from Stevens-Johnson syndrome or toxic epidermal necrolysis.
Sotozono C; Yamauchi N; Maeda S; Kinoshita S
Am J Ophthalmol; 2014 Nov; 158(5):983-93. PubMed ID: 25036881
[TBL] [Abstract][Full Text] [Related]
16. The current understanding of Stevens-Johnson syndrome and toxic epidermal necrolysis.
Mockenhaupt M
Expert Rev Clin Immunol; 2011 Nov; 7(6):803-13; quiz 814-5. PubMed ID: 22014021
[TBL] [Abstract][Full Text] [Related]
17. Intravenous immune globulin therapy for Stevens-Johnson syndrome/toxic epidermal necrolysis complicated by hemolysis leading to pigment nephropathy and hemodialysis.
Ririe MR; Blaylock RC; Morris SE; Jung JY
J Am Acad Dermatol; 2013 Aug; 69(2):221-5. PubMed ID: 23673282
[TBL] [Abstract][Full Text] [Related]
18. Toxic epidermal necrolysis in children: medical, surgical, and ophthalmologic considerations.
Goyal S; Gupta P; Ryan CM; Kazlas M; Noviski N; Sheridan RL
J Burn Care Res; 2009; 30(3):437-49. PubMed ID: 19349890
[TBL] [Abstract][Full Text] [Related]
19. A 2-year-old girl with Stevens--Johnson syndrome/toxic epidermal necrolysis treated with intravenous immunoglobulin.
Arca E; Köse O; Erbil AH; Nişanci M; Akar A; Gür AR
Pediatr Dermatol; 2005; 22(4):317-20. PubMed ID: 16060867
[TBL] [Abstract][Full Text] [Related]
20. Toxic Epidermal Necrolysis and Steven-Johnson Syndrome: A Comprehensive Review.
Charlton OA; Harris V; Phan K; Mewton E; Jackson C; Cooper A
Adv Wound Care (New Rochelle); 2020 Jul; 9(7):426-439. PubMed ID: 32520664
[No Abstract] [Full Text] [Related]
[Next] [New Search]
